Meta‐analysis of aggregate data on medical events
暂无分享,去创建一个
[1] Karl Pearson,et al. Mathematical contributions to the theory of evolution, On the law of ancestral heredity , 1898, Proceedings of the Royal Society of London.
[2] G. Yule. NOTES ON THE THEORY OF ASSOCIATION OF ATTRIBUTES IN STATISTICS , 1903 .
[3] E. H. Simpson,et al. The Interpretation of Interaction in Contingency Tables , 1951 .
[4] David R. Cox,et al. Regression models and life tables (with discussion , 1972 .
[5] S J Pocock,et al. The combination of randomized and historical controls in clinical trials. , 1976, Journal of chronic diseases.
[6] G. Glass. Primary, Secondary, and Meta-Analysis of Research1 , 1976 .
[7] M. Gail,et al. Biased estimates of treatment effect in randomized experiments with nonlinear regressions and omitted covariates , 1984 .
[8] Tony Lancaster,et al. Generalised residuals and heterogeneous duration models: With applications to the Weilbull model , 1985 .
[9] J M Lachin,et al. Evaluation of sample size and power for analyses of survival with allowance for nonuniform patient entry, losses to follow-up, noncompliance, and stratification. , 1986, Biometrics.
[10] L. Ryan,et al. Issues of efficiency in combining proportions of deaths from several clinical trials. , 1987, Statistics in medicine.
[11] M. S. Patel,et al. An introduction to meta-analysis. , 1989, Health Policy.
[12] D J Greenblatt,et al. Pharmacokinetics and pharmacodynamics. , 1990, Hospital practice.
[13] A Whitehead,et al. A general parametric approach to the meta-analysis of randomized clinical trials. , 1991, Statistics in medicine.
[14] Luis A. Escobar,et al. Statistical Intervals: A Guide for Practitioners , 1991 .
[15] N. Jewell,et al. A geometric approach to assess bias due to omitted covariates in generalized linear models , 1993 .
[16] StatisticsHarvard,et al. Avoiding model selection in Bayesian social research , 1994 .
[17] Nitin R. Patel,et al. Exact logistic regression: theory and examples. , 1995, Statistics in medicine.
[18] Paul D. Allison,et al. Survival analysis using sas®: a practical guide , 1995 .
[19] D J Spiegelhalter,et al. Bayesian approaches to random-effects meta-analysis: a comparative study. , 1995, Statistics in medicine.
[20] A Whitehead,et al. Borrowing strength from external trials in a meta-analysis. , 1996, Statistics in medicine.
[21] N. Black. CONSORT , 1996, The Lancet.
[22] M. Parmar,et al. Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints. , 1998, Statistics in medicine.
[23] N Breslow,et al. Generalized linear mixed models for meta-analysis. , 1999, Statistics in medicine.
[24] A. Gelfand,et al. Identifiability, Improper Priors, and Gibbs Sampling for Generalized Linear Models , 1999 .
[25] John M. Lachin,et al. Biostatistical Methods: The Assessment of Relative Risks , 2000 .
[26] A. Agresti,et al. Strategies for comparing treatments on a binary response with multi-centre data. , 2000, Statistics in medicine.
[27] S Greenland,et al. Small-sample bias and corrections for conditional maximum-likelihood odds-ratio estimators. , 2000, Biostatistics.
[28] C. Veyrat‐Follet,et al. Clinical trial simulation of docetaxel in patients with cancer as a tool for dosage optimization , 2000, Clinical pharmacology and therapeutics.
[29] M Schemper,et al. A Solution to the Problem of Monotone Likelihood in Cox Regression , 2001, Biometrics.
[30] Paula R Williamson,et al. Aggregate data meta‐analysis with time‐to‐event outcomes , 2002, Statistics in medicine.
[31] M. Schemper,et al. A solution to the problem of separation in logistic regression , 2002, Statistics in medicine.
[32] M. Symons,et al. Hazard rate ratio and prospective epidemiological studies. , 2002, Journal of clinical epidemiology.
[33] M. May. Bayesian Survival Analysis. , 2002 .
[34] Nicola J Cooper,et al. Meta-analysis of rare and adverse event data , 2002, Expert review of pharmacoeconomics & outcomes research.
[35] Antonio Lijoi,et al. Approximating priors by finite mixtures of conjugate distributions for an exponential family , 2003 .
[36] J. Ibrahim,et al. Conjugate priors for generalized linear models , 2003 .
[37] William J. Browne,et al. Bayesian and likelihood-based methods in multilevel modeling 1 A comparison of Bayesian and likelihood-based methods for fitting multilevel models , 2006 .
[38] Karim F. Hirji,et al. Exact Analysis of Discrete Data , 2005 .
[39] Gary H Lyman,et al. The strengths and limitations of meta-analyses based on aggregate data , 2005, BMC Medical Research Methodology.
[40] David R. Jones,et al. How vague is vague? A simulation study of the impact of the use of vague prior distributions in MCMC using WinBUGS , 2005, Statistics in medicine.
[41] J. Davis. Univariate Discrete Distributions , 2006 .
[42] Kenneth Liu,et al. Confidence intervals for an exposure adjusted incidence rate difference with applications to clinical trials , 2006, Statistics in medicine.
[43] Joel B Greenhouse,et al. Do antidepressants cause suicidality in children? A Bayesian meta-analysis , 2006, Clinical trials.
[44] C. Adams,et al. The Leeds Evaluation of Efficacy of Detoxification Study (LEEDS) prisons project pilot study: protocol for a randomised controlled trial comparing dihydrocodeine and buprenorphine for opiate detoxification , 2007, Trials.
[45] S. Nissen,et al. Effect of rosiglitazone on the risk of myocardial infarction and death from cardiovascular causes. , 2007, The New England journal of medicine.
[46] Stephen Senn,et al. (www.interscience.wiley.com) DOI: 10.1002/sim.2639 Trying to be precise about vagueness , 2022 .
[47] M. Sydes,et al. Practical methods for incorporating summary time-to-event data into meta-analysis , 2007, Trials.
[48] Christian P. Robert,et al. The Bayesian choice : from decision-theoretic foundations to computational implementation , 2007 .
[49] Jonathan J Deeks,et al. Much ado about nothing: a comparison of the performance of meta‐analytical methods with rare events , 2007, Statistics in medicine.
[50] M. G. Pittau,et al. A weakly informative default prior distribution for logistic and other regression models , 2008, 0901.4011.
[51] S. Senn. Lessons from TGN1412 and TARGET: implications for observational studies and meta‐analysis , 2008, Pharmaceutical statistics.
[52] Alan Agresti,et al. A Step-by-Step Approach to Using SAS for Univariate & Multivariate Statistics, 2nd Edition + An Introduction to Categorical Data Analysis, 2nd Edition , 2008 .
[53] Richard D Riley,et al. Meta‐analysis of continuous outcomes combining individual patient data and aggregate data , 2008, Statistics in medicine.
[54] Norman E. Fenton,et al. Modelling dependable systems using hybrid Bayesian networks , 2008, Reliab. Eng. Syst. Saf..
[55] Theo Stijnen,et al. Meta‐analysis of summary survival curve data , 2008, Statistics in medicine.
[56] P. Bagos,et al. Mixed-Effects Poisson Regression Models for Meta-Analysis of Follow-Up Studies with Constant or Varying Durations , 2009 .
[57] H. Wunsch,et al. Use of intensive care services during terminal hospitalizations in England and the United States. , 2009, American journal of respiratory and critical care medicine.
[58] M. Coory,et al. Bayesian versus frequentist statistical inference for investigating a one-off cancer cluster reported to a health department , 2009, BMC medical research methodology.
[59] James G. Scott,et al. Handling Sparsity via the Horseshoe , 2009, AISTATS.
[60] Theo Stijnen,et al. Random effects meta‐analysis of event outcome in the framework of the generalized linear mixed model with applications in sparse data , 2010, Statistics in medicine.
[61] Richard D Riley,et al. Meta‐analysis of a binary outcome using individual participant data and aggregate data , 2010, Research synthesis methods.
[62] Tianxi Cai,et al. Meta‐analysis for rare events , 2010, Statistics in medicine.
[63] A. Ismaila,et al. A tutorial on pilot studies: the what, why and how , 2010, BMC Medical Research Methodology.
[64] D. Moher,et al. CONSORT 2010 Statement: updated guidelines for reporting parallel group randomized trials , 2010, Obstetrics and gynecology.
[65] Neil Hawkins,et al. Network meta-analysis on the log-hazard scale, combining count and hazard ratio statistics accounting for multi-arm trials: A tutorial , 2010, BMC medical research methodology.
[66] Bradley P Carlin,et al. Hierarchical Commensurate and Power Prior Models for Adaptive Incorporation of Historical Information in Clinical Trials , 2011, Biometrics.
[67] Nicky J Welton,et al. NICE DSU Technical Support Document 2: A Generalised Linear Modelling Framework for Pairwise and Network Meta-Analysis of Randomised Controlled Trials , 2011 .
[68] Rebecca M Turner,et al. Characteristics of meta-analyses and their component studies in the Cochrane Database of Systematic Reviews: a cross-sectional, descriptive analysis , 2011, BMC medical research methodology.
[69] C. McCulloch,et al. Misspecifying the Shape of a Random Effects Distribution: Why Getting It Wrong May Not Matter , 2011, 1201.1980.
[70] J. Higgins. Cochrane handbook for systematic reviews of interventions. Version 5.1.0 [updated March 2011]. The Cochrane Collaboration , 2011 .
[71] W. Henley,et al. Improved curve fits to summary survival data: application to economic evaluation of health technologies , 2011, BMC Medical Research Methodology.
[72] R. Rosenheck,et al. Joint modelling of longitudinal outcome and interval‐censored competing risk dropout in a schizophrenia clinical trial , 2012, Journal of the Royal Statistical Society. Series A,.
[73] Joseph G Ibrahim,et al. Bayesian Meta‐Experimental Design: Evaluating Cardiovascular Risk in New Antidiabetic Therapies to Treat Type 2 Diabetes , 2012, Biometrics.
[74] Richard D Riley,et al. Individual patient data meta-analysis of survival data using Poisson regression models , 2012, BMC Medical Research Methodology.
[75] Jean-Michel Marin,et al. Approximate Bayesian computational methods , 2011, Statistics and Computing.
[76] S. Golder,et al. Systematic review of methods used in meta-analyses where a primary outcome is an adverse or unintended event , 2012, BMC Medical Research Methodology.
[77] Gagandeep Kang,et al. Analysis of human immune responses in quasi-experimental settings: tutorial in biostatistics , 2012, BMC Medical Research Methodology.
[78] Hans-Peter Piepho,et al. The Use of Two‐Way Linear Mixed Models in Multitreatment Meta‐Analysis , 2012, Biometrics.
[79] Adrian E. Raftery,et al. mclust Version 4 for R : Normal Mixture Modeling for Model-Based Clustering , Classification , and Density Estimation , 2012 .
[80] Nicky J Welton,et al. Enhanced secondary analysis of survival data: reconstructing the data from published Kaplan-Meier survival curves , 2012, BMC Medical Research Methodology.
[81] Rafael Perera,et al. New treatments compared to established treatments in randomized trials ( Review ) , 2022 .
[82] Peter W Lane,et al. Meta-analysis of incidence of rare events , 2013, Statistical methods in medical research.
[83] Richard F MacLehose,et al. Sensitivity Analyses for Sparse-Data Problems—Using Weakly Informative Bayesian Priors , 2013, Epidemiology.
[84] Evangelos Kontopantelis,et al. A Re-Analysis of the Cochrane Library Data: The Dangers of Unobserved Heterogeneity in Meta-Analyses , 2013, PloS one.
[85] Sophia Rabe-Hesketh,et al. Avoiding zero between‐study variance estimates in random‐effects meta‐analysis , 2013, Statistics in medicine.
[86] John W Seaman,et al. Comparison of Bayesian and Frequentist Meta-Analytical Approaches for Analyzing Time to Event Data , 2013, Journal of biopharmaceutical statistics.
[87] M. Betancourt,et al. Hamiltonian Monte Carlo for Hierarchical Models , 2013, 1312.0906.
[88] Alex J Sutton,et al. Hierarchical network meta‐analysis models to address sparsity of events and differing treatment classifications with regard to adverse outcomes , 2014, Statistics in medicine.
[89] K. Lee,et al. Korean translation of the CONSORT 2010 Statement: updated guidelines for reporting parallel group randomized trials , 2014, Epidemiology and health.
[90] Anthony O'Hagan,et al. Robust meta‐analytic‐predictive priors in clinical trials with historical control information , 2014, Biometrics.
[91] Andrew Gelman,et al. The No-U-turn sampler: adaptively setting path lengths in Hamiltonian Monte Carlo , 2011, J. Mach. Learn. Res..
[92] S. Normand,et al. Meta‐analysis of rate ratios with differential follow‐up by treatment arm: inferring comparative effectiveness of medical devices , 2015, Statistics in medicine.
[93] D Zeng,et al. Equity-specific effects of interventions to promote physical activity among middle-aged and older adults: results from applying a novel equity-specific re-analysis strategy , 2021, International Journal of Behavioral Nutrition and Physical Activity.
[94] D. Kault,et al. From P-Values to Objective Probabilities in Assessing Medical Treatments , 2015, PloS one.
[95] Patrick Royston,et al. Meta‐analysis of time‐to‐event outcomes from randomized trials using restricted mean survival time: application to individual participant data , 2015, Statistics in medicine.
[96] Kalliopi Mylona,et al. Meta‐analysis of clinical trials with rare events , 2015, Biometrical journal. Biometrische Zeitschrift.
[97] Joseph G Ibrahim,et al. The power prior: theory and applications , 2015, Statistics in medicine.
[98] O Kuss,et al. Statistical methods for meta‐analyses including information from studies without any events—add nothing to nothing and succeed nevertheless , 2015, Statistics in medicine.
[99] Nicholas G. Polson,et al. Default Bayesian Analysis with Global-Local Shrinkage Priors , 2015, 1510.03516.
[100] M. Fischereder,et al. Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes. , 2016, The New England journal of medicine.
[101] Qi Jiang,et al. Statistical Monitoring of Safety in Clinical Trials , 2016 .
[102] Heinz Schmidli,et al. On the Use of Co-Data in Clinical Trials , 2016 .
[103] R. Bender,et al. Performance of the Peto odds ratio compared to the usual odds ratio estimator in the case of rare events , 2016, Biometrical journal. Biometrische Zeitschrift.
[104] Bayesian Estimation and Testing in Random Effects Meta-Analysis of Rare Binary Adverse Events , 2016, Statistics in biopharmaceutical research.
[105] Control charts for monitoring accumulating adverse event count frequencies from single and multiple blinded trials , 2016, Statistics in medicine.
[106] John A Scott,et al. Addressing prior-data conflict with empirical meta-analytic-predictive priors in clinical studies with historical information , 2016, Journal of biopharmaceutical statistics.
[107] David Ohlssen,et al. Strategies on Using Prior Information When Assessing Adverse Events , 2016 .
[108] C Combescure,et al. Meta-analysis of two-arm studies: Modeling the intervention effect from survival probabilities , 2016, Statistical methods in medical research.
[109] Satrajit Roychoudhury,et al. Robust exchangeability designs for early phase clinical trials with multiple strata , 2016, Pharmaceutical statistics.
[110] Admin Wiley,et al. Dataset for: Meta-analysis of aggregate data on medical events , 2017 .
[111] Tim Friede,et al. Meta‐analysis of few small studies in orphan diseases , 2016, Research synthesis methods.
[112] N. Wald,et al. Sharing Clinical Trial Data , 2017, Journal of medical screening.
[113] Jiqiang Guo,et al. Stan: A Probabilistic Programming Language. , 2017, Journal of statistical software.
[114] Richard D. Riley,et al. Random effects meta‐analysis: Coverage performance of 95% confidence and prediction intervals following REML estimation , 2016, Statistics in medicine.
[115] Sean Khozin,et al. Advantages of a Truly Open-Access Data-Sharing Model. , 2017, The New England journal of medicine.
[116] Clemens Elster,et al. Bayesian estimation in random effects meta‐analysis using a non‐informative prior , 2017, Statistics in medicine.